1. Academic Validation
  2. Chemical constituents from Carica papaya Linn. leaves as potential cytotoxic, EGFRwt and aromatase (CYP19A) inhibitors; a study supported by molecular docking

Chemical constituents from Carica papaya Linn. leaves as potential cytotoxic, EGFRwt and aromatase (CYP19A) inhibitors; a study supported by molecular docking

  • RSC Adv. 2022 Mar 23;12(15):9154-9162. doi: 10.1039/d1ra07000b.
Ashraf N E Hamed 1 Mohamed E Abouelela 2 Ahmed E El Zowalaty 3 4 5 Mohamed M Badr 6 Mohamed S A Abdelkader 7
Affiliations

Affiliations

  • 1 Department of Pharmacognosy, Faculty of Pharmacy, Minia University Minia 61519 Egypt.
  • 2 Department of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University Assiut-Branch Assiut 71524 Egypt.
  • 3 Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg 40530 Gothenburg Sweden.
  • 4 Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg 40530 Gothenburg Sweden.
  • 5 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University 44519 Egypt.
  • 6 Department of Biochemistry, Faculty of Pharmacy, Menoufia University Menoufia 32511 Egypt.
  • 7 Department of Pharmacognosy, Faculty of Pharmacy, Sohag University Sohag 82524 Egypt m.salaheldin@pharm.sohag.edu.eg.
Abstract

The phytochemical investigation of the hydromethanolic extract of Carica papaya Linn. leaves (Caricaceae) resulted in the isolation and characterization of ten compounds, namely; carpaine (1), methyl gallate (2), loliolide (3), rutin (4), clitorin (5), kaempferol-3-O-neohesperidoside (6), isoquercetin (7), nicotiflorin (8) and isorhamnetin-3-O-β-d-glucopyranoside (9). The compounds 2, 3, 5-7 and 9 were isolated for the first time from the genus Carica. An in vitro breast Cancer cytotoxicity study was evaluated with an MCF-7 cell line using the MTT assay. Methyl gallate and clitorin demonstrated the most potent cytotoxic activities with an IC50 of 1.11 ± 0.06 and 2.47 ± 0.14 μM, respectively. Moreover, methyl gallate and nicotiflorin exhibited potential EGFRwt kinase inhibition activities with an IC50 of 37.3 ± 1.9 and 41.08 ± 2.1 nM, respectively, compared with the positive control erlotinib (IC50 = 35.94 ± 1.8 nM). On the Other hand, clitorin and nicotiflorin displayed the strongest aromatase kinase inhibition activities with an IC50 of 77.41 ± 4.53 and 92.84 ± 5.44 nM, respectively. Clitorin was comparable to the efficacy of the standard drug letrozole (IC50 = 77.72 ± 4.55). Additionally, molecular docking simulations of the isolated compounds to EGFR and human placental aromatase Cytochrome P450 (CYP19A1) were evaluated. Methyl gallate linked with the EGFR receptor through hydrogen bonding with a pose score of -4.5287 kcal mol-1 and RMSD value of 1.69 Å. Clitorin showed the strongest interaction with aromatase (CYP19A1) for the breast Cancer receptor with a posing score of -14.2074 and RMSD value of 1.56 Å. Compounds (1-3) possessed a good bioavailability score with a 0.55 value.

Figures
Products